Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer
Conclusions:
Protons delivered comparable doses to targets in dose homogeneity and conformity and spared normal tissues from intermediate-to-low doses better than IMRT did. Further improvement of dose sparing and changes in homogeneity and conformity may be achieved by reducing proton range uncertainties and from implementing intensity modulation.
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Inhwan YeoPrashanth NookalaIan GordonReinhard SchulteStanley BarnesAbiel GhebremedhinNing WangGary YangTed LingDavid BushJerry SlaterBaldev Patyal Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Computers | Intensity-Modulated Radiation Therapy | Penile Cancer | PET Scan | Prostate Cancer | Proton Therapy | Radiation Therapy | Study